Why the study?
The left subclavian artery is an infrequently used alternative access route for TAVR in patients with severe peripheral artery disease.
Does a transaxillary approach via prosthetic conduit provide safe access for TAVR in patients with severe peripheral artery disease?
Observational (n=10)
No
Does a transaxillary approach via prosthetic conduit provide safe access for TAVR in patients with severe peripheral artery disease?
The transaxillary approach via a prosthetic conduit is a feasible and safe alternative access route for TAVR in patients with severe peripheral artery disease who lack standard access options.
Axillary conduit access feasible in severe PAD; leaves open need for comparative safety data on stroke risk.
Background: The left subclavian artery (LSA) is an infrequently used alternative access route for patients with severe peripheral artery disease (PAD) in patients who underwent transcatheter aortic valve replacement (TAVR). We report a new endovascular approach for TAVR combining an axillary prosthetic conduit-based access technique with new-generation balloon-expandable TAVR prostheses. Methods and Results: Between January 2020 and December 2020, 251 patients underwent TAVR at the West German Heart and Vascular Center. Of these, 10 patients (3.9%) were deemed to be treated optimally by direct surgical exposure of the left or right axillary artery via a surgically adapted prosthetic conduit. All procedures were performed under general anesthesia. One procedural stroke occurred due to severe calcification of the aortic arch. No specific complications of the subclavian access site (vessel rupture, vertebral, or internal mammary ischemia) were reported. Two minor bleedings from the access site could be treated conservatively. No surgical revision was necessary. Conclusion: The axillary prosthetic conduit-based access technique using new-generation balloon-expandable valves allows safe and successful TAVR in a subgroup of patients with a high risk of procedural complications due to severe peripheral vascular disease. Considering the increasing number of patients referred for TAVR, this approach could represent an alternative for patients with limited access sites.
No takes yet. Share an insight, caveat, or question.
Lind et al. (2022) conducted an observational in Severe peripheral artery disease in patients undergoing transcatheter aortic valve replacement (n=10). Axillary prosthetic conduit-based access technique with new-generation balloon-expandable TAVR prostheses was evaluated on Procedural complications (including stroke, access site complications, bleeding, and surgical revision).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: